Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest
Sponsor
Radboud University Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT00441753
Collaborator
(none)
10
1
Study Details
Study Description
Brief Summary
Survivors of a cardiac arrest frequently develop severe postanoxic encephalopathy. Derangements in cerebral blood after return of spontaneous circulation play an important role in the pathogenesis of postanoxic encephalopathy. In the present study we examine the effect of mild therapeutic hypothermia on cerebral blood flow and carbondioxide reactivity in patients after cardiac arrest.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
10 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest
Study Start Date
:
Sep 1, 2006
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 95 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
adult patients
-
GCS after return of circulation < 7
-
Induced mild hypothermia for 24 hours
-
primary rhythm ventricular fibrillation
Exclusion Criteria:
-
Thrombolysis
-
Cardiogenic shock with expected survival < 24 hrs
-
Pregnancy
-
No informed consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Radboud University Nijmegen Medical Centre | Nijmegen | Netherlands | 6500 HB |
Sponsors and Collaborators
- Radboud University Medical Center
Investigators
- Principal Investigator: Cornelia Hoedemaekers, MD PhD, Radboud University Medical Center
- Study Director: Johannes van der Hoeven, MD PhD, Radboud University Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00441753
Other Study ID Numbers:
- KSCH0601
First Posted:
Mar 1, 2007
Last Update Posted:
Feb 6, 2009
Last Verified:
Feb 1, 2009